Trials / Completed
CompletedNCT01034176
BK Treatment Study
Effect of Fluoroquinolones on BK Viremia in the Renal Transplant Recipient, A Multi-Center Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our hypothesis is that 30 days of oral levofloxacin (FDA approved antibiotic) in patients with persistent viremia (BK virus found in blood) will impair progress to BK virus induced kidney damage by significantly decreasing or eliminating BK virus in the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levofloxacin | 500 mg tablet, daily, 30 days |
| DRUG | placebo | no dose, tablet, daily, 30 days |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-10-01
- First posted
- 2009-12-17
- Last updated
- 2017-04-24
- Results posted
- 2017-03-06
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01034176. Inclusion in this directory is not an endorsement.